Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InScent is an Israel-based biotechnology company specializing in the development of scent-based diagnostic tools for the early detection of neurodegenerative and infectious diseases. The company's core technology leverages the human olfactory system and advanced sensory analysis to identify unique chemical signatures associated with specific pathologies, most notably Parkinson's disease. By utilizing non-invasive scent tests, InScent aims to provide a low-cost, highly accurate screening method that can detect diseases years before the onset of motor symptoms. The company is also exploring the application of its platform for the rapid detection of other conditions, including COVID-19, through volatile organic compound (VOC) analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inscent.